Clinical Trial: A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07213817) titled 'A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours' on Oct. 01.

Brief Summary: This study aims to find the right dosage and evaluate the safety and effectiveness of the drug IPN60300 in adults with advanced solid tumours, which are cancers that have spread to other parts of the body from their original location. All participants will receive the drug by injection.

Study Phases:

* Phase Ia: Participants with certain types of tumours will be treated in cohorts of increasingly higher doses of the d...